Introduction
Postpartum hemorrhage (PPH) is one of the main causes of maternal morbidity and mortality worldwide (1) (2) . PPH is defined as blood loss above 500 ml, measured up to 24 hours postpartum, while this amount of blood loss after 24 hours is defined as secondary PPH (1, 3) . Blood loss up to 500ml among healthy women does not lead to negative consequences;
however, uncontrolled blood loss over 500ml can be fatal (1) . Primary PPH occurs in the first 24 hours after birth and is more likely to result in maternal morbidity and mortality, while secondary postpartum hemorrhage refers to bleeding that occurs from 24 hours up to six weeks after birth (1, 3) .
In general, blood loss is diagnosed as PPH if one or more of the following occur: loss of uterine tone (atony); retention of placental tissue or blood clots;
laceration of the genital tract; or coagulopathy (1, 3) .
Procedures to prevent PPH are initiated by assessing a patient's risk profile and establishing how to respond to complications in order to prevent a small amount of bleeding from becoming a severe hemorrhage with the risk of death. PPH is one of the complications of the third stage of labor and this stage begins after the fetus is expelled; however, with the detaching of the placenta from the uterine wall and its expulsion through the birth canal, greater than expected bleeding may occur.
Therefore, it is essential to know the physiology of childbirth and women's clinical conditions, as well as intercurrences that took place during the pregnancypuerperal period, which might contribute to the emergence of hemorrhaging (1, 4) .
In order to prevent PPH, the staff needs to be prepared to use protocols with a multidisciplinary approach, which involves maintaining hemodynamic stability while, simultaneously, identifying and treating the cause of bleeding. A combination of prediction and prevention, early identification and rapid coordinated actions is essential to preventing PPH. Consequently, efficient communication among the members of the multidisciplinary obstetrical team is paramount (5) .
Prevention and control of PPH demand technologies that support labor and interventions in the event unwanted bleeding occurs. Therefore, health workers should be aware of and implement technologies supported by a higher level of evidence and with positive outcomes, which represent the least harm to women and babies.
Additionally, for safe and timely care to be provided, services need to have a well-established capacity to coordinate people, equipment and work processes.
Hence, having techniques and technologies as well as protocols does not ensure, by itself, the prevention and control of hemorrhaging; personnel of sufficient quality and number to meet demand is necessary.
Technologies, evidence-based practice, and interventions proposed by workers have grown exponentially in importance from the mid-twentieth century, so much so that providing quality services without such resources is inconceivable currently, with many of them being innovative in nature (6) . All these aspects a service is required to have are known as health technologies -a term that encompasses every intervention used to promote health. "In this sense, health technologies can be conceived as the practical application of knowledge, including machines, clinical and surgical procedures, medications, programs and systems intended to promote health care" (7) .
Similarly, the literature presents the elements that integrate health technologies, namely any and all methods/devices used to promote health, prevent death, and treat diseases and improve rehabilitation or the care of individuals or populations (8) . a scientific basis to strengthen healthcare delivery and produce evidence to innovate in regard to product and process technologies (9) (10) .
There are various systematic reviews addressing PPH showing it still accounts for high levels of morbidity and mortality, mainly in developing countries. For this reason, studies need to be conducted regularly, considering that all technologies should be revised and updated over time, especially when we consider the application of technologies in different contexts and populations (6) (7) (8) 11) .
In order to overcome the causes of PPH and its determinants of a sociocultural, technical and technological nature in different geo-economic contexts, the results of systematic reviews should be disseminated among health services in order to contribute to the development of multidisciplinary protocols. In this context, nurses, especially those in the obstetrical field, can propose care processes, among others, such as those associated with patient safety, especially when applying pharmacological products 11) .
Given the importance of hemorrhaging, which may be associated with diverse events such as uterine atony, uterine rupture, blood dyscrasia, cephalopelvic
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disproportion and placental abruption (1) , the need to prepare the staff to intervene appropriately, and lack of information regarding existing technologies in the field, the objective of this study was to identify evidence concerning the contribution of health technologies used to prevent and control hemorrhaging in the third stage of labor.
Method
This Systematic Review adopted the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist (12) After selecting the papers, the researchers held a meeting to reconcile agreements and disagreements by carefully consulting the full texts. Of the 48 papers selected, the researchers disagreed in regard to 10.
After discussion, they decided to include four of these papers, with 42 papers being included in the final review. The Kappa coefficient (14) (15) (16) (17) (18) , with a confidence interval of 95%, was applied to assess inter-rater agreement. This coefficient has the following measure levels: less than zero, "insignificant"; between 0 and 0.2, "weak"; between 0.21 and 0.40, "reasonable"; between 0.41 and 0.60, "moderate"; between 0.61 and 0.80, "strong"; and between 0.81 and 1.0, "almost perfect".
The levels of evidence identified in the papers were classified according to Grading of Recommendations Assessment, Development and Evaluation (GRADE) (19) (20) , a system sensitive to rating the quality of evidence.
In this system, quality of evidence is classified as:
high, moderate, low, or very low ( Figure 1 (19) . Rev. Latino-Am. Enfermagem 2019;27:e3165.
In this study, the classification used (the GRADE system) to assess the quality of evidence took into account (20) .
In the third stage of the process, after reading the full texts and excluding those that failed to meet the inclusion criteria, according to two independent researchers, we proceeded to the systematization of studies. 
Results
After applying the search strategies, 6,999 papers were found. Of these, 6,726 were excluded due to the following: the titles and/or abstracts of 5,978 papers did not meet the inclusion criteria; 652 papers were published in more than one database; and 96 were not characterized as papers (e.g., theses, dissertations, integrative literature reviews, descriptive observational studies, papers other than scientific research, and qualitative studies)
The full texts of 273 papers were read and 42
were included (Figure 2 ). The Kappa coefficient (14) (15) (16) (17) (18) , which was equal to 0.86 in the first stage and equal to 1.00 in the second, revealed a high level of inter-rater agreement. Systematic random sampling. Participants were assigned according to double-blind randomization, using computer-generated random numbers prepared by an independent statistician, and concealed for data analysis.
Opaque envelopes containing random numbers were opened in the third stage of labor.
The participants, caregivers and evaluators of outcomes were blind in regard to the groups' allocation 5.66% oxytocin group and 3.84% misoprostol group
--
Rajaei et al.
Simple randomization using computer-generated random numbers. Uncertain
Reported as double blind
Uncertain/does not report
A biostatistician generated a random list of 570 participants in each group.
The MRA* received opaque envelopes were labeled with study codes Participants and assessors were blind There was none
The participation of eligible participants decreased
Simple randomization using computer-generated random numbers.
Packaged in properly encoded envelopes
Reported as double blind
There was none
Used misoprostol instead of a placebo
Vagge et al. (25) Simple randomization.
Does not report

Uncertain
Patients were randomly assigned to two groups.
Does not report
Small sample
Tita et al. (27) Women were randomly assigned to one of the study's three groups according to confidential computer-generated block randomization algorithm
Bags numbered according to a randomization scheme
Reported as double blind none Sample was insufficient to respond to the primary outcome Gutarra-Vilchez et al. (28) Systematic randomization Uncertain/does not report
Patients and those involved in the investigation were blind Uncertain/does not report A physician assigned the patients to the groups Shrestha et al. (29) Randomization was performed when vaginal delivery was imminent.
Women were randomly assigned according to lottery technique.
Uncertain/does not report
Uncertain/does not report Uncertain/does not report
--
Güngördük et al. (30) Simple randomization using a random numbers list.
Oxytocin infusions were prepared and labeled as randomization bags
Patients and providers were blind 8.00% in the oxytocin group and 8.48% in the placebo group --Nasr et al. (31) Randomization to each group through a computer-generated random allocation system.
Sealed envelopes pre-prepared with computer-generated numbers
Reported as double blind
There was none --Caveda Gil et al. 
Randomization was performed using a random number list.
Both drugs were encoded and packaged before recruiting.
Patients and physicians were blind 9.00% in the carbetocin and 7.00% follow-up loss in the syntometrine group
--
Singh et al. (34) Randomization using computer-generated random numbers.
Drug packages were sealed and encoded using a computer-generated random number graph
The head nurse not involved in the study opened the assigned package; the researcher was blind for the package's content
Orji et al. (35) Randomly assigned to the oxytocin and ergometrine groups Sealed envelopes were used in the allocation
None
--
Uthman et al. (36) Prospective, randomized study.
Uncertain
Uncertain/there was none Uncertain/does not report
The method of blocked randomization was used and the participants were randomly assigned.
Opaque and sealed envelopes containing details of allocation were used
Researchers and data analysts were blind in regard to assignment
There was none Small sample Zachariah et al.
All women who experienced vaginal births were randomly assigned to one of the three groups using computer-generated random numbers.
Medication was given according to randomization
None
Uncertain/does not report 
Computer-generated random allocation was supervised by the Gynuity Health Projects, clusters
Medications were packaged in single-dose envelopes with individual numbering None 27.54% misoprostol group and 22.54% oxytocin group
Cannot report on uterotonic coverage at the community level.
Zuberi et al.
The sample was randomized into blocks of ten and stratified by site using a computer-generated random sequence.
Envelopes contained three misoprostol or placebo tablets
All women, providers, and researchers were blind in regard to the treatment assignment Uncertain/does not report
Small sample
Patil (42) Each of the patients was assigned to one of the groups using the colored coin method (random sampling method)
Not reported None
--
Ononge et al. (43) Randomization was obtained using a computer-generated numeric 
Randomization was obtained using a computer-generated random code Medication was packaged in numbered boxes encoded by colors to identify randomization sequence All women and midwives were blind in regard to the study's task 3.53% misoprostol group and 4.28% in the placebo group
Randomization was obtained using a computer-generated random block size
Envelopes were numbered and each envelop had a five-digit code number assigned to it Uncertain 0.36% in the misoprostol group and 0.12% in the placebo group
Harriott et al. 
Randomization was computer generated and stratified by country
To conceal the allocation, treatment boxes were sealed and numbered.
The workers and participants were blind in regard to the assignment of treatment
There was none --
A sequence of random numbers generated by computer was used for random allocation and stratified by country
Medications were placed in identical packages in terms of form, color, weight and feeling.
Reported as double blind 0.18% in the misoprostol group and 0.54% in the placebo group
Miller et al. The randomization list with intervention mode allocation was sent to the Hospital Pharmacy Both medications were packaged and encoded.
Midwives, obstetricians and participants were blind
There was none --Ducloy-Bouthors et al. (52) Computer-generated random sequence Uncertain Assessment of each endpoint was performed with researchers blind in regard to assignment of treatment 6.49% in the tranexamic and 2.70% in the placebo group
Small sample
Zhang et al. (53) The maternities were randomly assigned to groups using collector bags after vaginal delivery and not using collector bags
Not reported
Reported as double blind
There was none --Jangsten et al. (54) Women were assigned to active or expectant management using computer-generated randomization Sealed envelopes were prepared in consecutive order
The pregnant women were blind Randomization was done by using standardized forms assigned to each group Allocation was concealed by using sealed opaque envelopes.
Uncertain, not reported 1.80% active management group and 2.67% expectant management group
Computer-generated random sequence obtained at the WHO** ¶ A computer was programmed with a random sequence of allocation developed with the women's information, which were entered in the computer by local researchers. In Egypt and Kenya, sealed opaque envelopes had to be used instead, due to breach and theft in the middle of the process.
Neither the researchers nor the participants could be blinded for the interventions or outcomes 5.12% active simplified management group and 3.50% active complete group --Althabe et al. (57) Randomization was stratified per hospital and the sequence generated in the coordinating center with computer-generated random block numbers Women were assigned using sequence numbers and sealed opaque envelopes.
When childbirth was imminent, a midwife registered the patient on the next numbered envelope and communicated the intervention assigned to the assistant 
The participants were assigned according to computer-generated random allocation
Numbered opaque envelopes containing random allocations were kept in the delivery room at each study site.
No blinding was used due to the nature of the intervention.
Cluster randomization was obtained using a random number generator available at SAS ‡ ‡
Uncertain Uncertain
The control group did not receive any intervention Rev. Latino-Am. Enfermagem 2019;27:e3165.
The papers were classified as product and process technologies (9) . Among the 34 papers , when compared to other drugs, regardless of the dosage and route of administration, with the exception of one study (32) .
In regard to blood loss, six studies (22, 24, (32) (33) (34) (35) report that oxytocin presented a mean blood loss. Birth spacing influences this result; that is, greater blood loss in found among childbirths with intervals of less than two years (36) . Other studies (21, (25) (26) 28, 30) did not report significant differences in regard to this aspect. . Other studies (22, 24) , however, presented a greater occurrence of PPH in the oxytocin group, requiring a greater use of additional uterotonics in this group. The employment of oxytocin in intervals shorter than two years between births determined a greater occurrence of PPH (36) . Additionally, a drop in the concentration of hematocrit in the oxytocin group was significant in the postpartum (24, 32) .
The administration of oxytocin, even by unskilled individuals, was efficacious to control PPH and also to decrease blood loss, as well as the need to refer patients to referral units (39) . One study (40) , however, reports greater amounts of blood loss in the oxytocin group.
The use of misoprostol was analyzed in studies with different compositions and administration routes to prevent PPH (21) (22) (23) (24) (25) (26) 29, (31) (32) 37, 41) . These studies show that, regardless of the dosage of misoprostol, the duration of the third stage of the labor did not present significant differences, nor did the drop in the concentration of hematocrit/hemoglobin, except in those papers (24, 32) that found a decrease in the concentration of these hematological components.
Studies report that both that the duration of the third period of labor and mean loss of blood were significantly longer and greater (23, 29, (42) (43) and shorter and lower (22, 24, 32, 34, 37, 41) .The occurrence of PPH and/or severe PPH was greater among women who received misoprostol (22, (43) (44) . The RCTs (21, 26, 32, 36, 46) report that misoprostol was more efficacious in preventing PPH among women with inadequate birth spacing, that is, less than two years. This drug/dosage/route was Rangel RCT, Souza ML, Bentes CML, Souza ACRH, Leitão MNC, Lynn FA.
effective when used in the treatment of primary PPH caused by uterine atony (59) .
When considering the route of administration, sublingual misoprostol was more efficacious, decreasing the duration of the third stage of labor and mean blood loss in comparison to the rectal and oral routes.
Conversely, side effects like fever and tremors were more frequent when the sublingual route was used.
The group who received the medication through the oral route presented a greater need for additional uterotonics. In terms of acceptability, rectal misoprostol was better accepted by women and was the one with fewer side effects (46) (47) .
Side effects were common in all women who received misoprostol. Most studies comparing oxytocin to misoprostol report significant differences in which groups treated with misoprostol experienced more side effects, especially tremors and fever (21) (22) (23) (24) (25) (26) 29, 31, 34, (37) (38) 42, (44) (45) (47) (48) (49) (50) , with the exception of one study (32) that did not report significant differences.
Other symptoms like nausea, vomiting and diarrhea were found, but no significant differences were found between groups (21-26, 29, 31, 38, 43, 50) .
Seven studies (21, 23, 25, 31, (43) (44) (45) recommend misoprostol be adopted in areas where routine uterotonics are not available, as it is the best option to prevent PPH, given its ease of application, stability at ambient temperature and low cost. This is a safe and efficacious alternative to be used by midwives and auxiliaries in home births.
Misoprostol is the most viable choice in communities (40) and is easy to store (42) . In areas where there are routine uterotonics available, however, the benefits of misoprostol might not outweigh the discomfort of side effects (49) .
In regard to the viability of using misoprostol in communities, a study that distributed it during prenatal care for women to self-administer it at home, no significant decrease of PPH was found. Nonetheless, the use of uterotonics increased as did the return visits of women to the health service. The self-administration of misoprostol with little monitoring and supervision was considered safe (43) , though women need to be better educated on when to use misoprostol in regard to placental deconditioning.
In regard to misoprostol, RCTs present a high level of evidence (21, 24, 31, 34, 40, 44, 50) recommending the use of this uterotonic via the oral, sublingual and rectal routes in different dosages, indicating it is efficacious, economically viable and easy to administer.
Therefore, the use of misoprostol in areas with few resources is a good alternative to oxytocin. Analysis of bias indicated there were no methodological limitations regarding the design or implementation of the individual papers presented. The RCTs (43, 59) with moderate evidence indicate that oral misoprostol is the only pharmacological option available in areas with few resources to prevent postpartum hemorrhaging and bleeding. Other studies (25) (26) 29, (41) (42) (43) 46) addressed in this review and that address the use of misoprostol also make similar recommendations but, in accordance with GRADE ( Figure 3) , present methodological limitations.
Further studies need to focus on the potential efficacy of misoprostol in areas where standard uterotonics are not available.
In regard to the use of oxytocin, RCTs with moderate level of evidence (35, 39) recommend the prophylactic use of misoprostol to prevent PPH, while this is an essential intervention. Thus, oxytocin is the drug of choice whenever available and with a 10UI dosage; it is as efficacious as ergometrine in decreasing the incidence of PPH, though without the undesirable side effects associated with ergometrine. These studies present methodological limitations regarding the blinding of participants.
As noted in the previous paragraph, in addition to misoprostol and oxytocin, the efficacy of ergometrine, syntometrine and PGF2α in preventing PPH was also compared. Studies addressing ergometrine (33) (34) (35) 38) report no significant differences in regard to the remaining uterotonics assessed in terms of blood loss, drop in hematocrit, duration of the third stage of labor, or the additional need of other drugs. The risk of side effects (nausea, high blood pressure, headaches and vomiting), however, was greater in the group receiving ergometrine.
For this reason, the recommendation to use ergometrine depends on the relevance of risks (35) .
In regard to syntometrine, the studies intending to determine the severity and incidence of this drug's side effects report no significant differences in terms of the duration of the third stage of labor, amount of blood loss, and use of additional uterotonics (33, 46) . Significant differences, however, were reported by another study (51) , in regard to nausea, tremors, vomiting, uterine pain, and sweating.
In the comparison performed between syntometrine and carbetocin in the prevention of PPH (33, 51) , carbetocin was more efficacious than syntometrine, though one of the studies (51) does not report relevant differences between the efficacies of both. The study with carbetocin identified fewer side effects and, even though an analysis of cost/efficacy was not performed, the author reports that the cost of carbetocin is ten times greater than the cost of syntometrine, while emphasizing that carbetocin was associated with fewer side effects, so that its use can contribute to reduced costs and time required for professionals.
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PGF2α in one RCT (42) was more efficacious than misoprostol in decreasing mean blood loss and the duration of the third stage of labor and the drop in hemoglobin levels. The associated gastrointestinal side effects, however, were significantly greater and included nausea, vomiting, diarrhea and abdominal cramps.
One RCT (50) conducted in China addressed the ZB11 uterotonic, used in Tibetan traditional medicine to prevent PPH. The results show higher rates of PPH in the ZB11 group in comparison to the misoprostol group. No significant differences were found in terms of blood loss.
Side effects such as diarrhea, tremors, and fever were less recurrent. The authors (50) suggest that other studies be undertaken in that geographic area because home births performed by the pregnant women themselves, or without the assistance of qualified workers, is not uncommon. Thus, research addressing efficacious uterotonics with accessible prices is especially relevant in areas with these characteristics and can contribute to women's easier access to safe technologies (50) . This specific RCT was assessed using the GRADE system and was considered to have a high level of evidence, presenting no methodological limitations.
Another drug that was addressed in order to verify its efficacy and safety in preventing and treating PPH was tranexamic acid (TA) (52) . The authors covering this drug report that high dosages of TA can decrease blood loss and maternal morbidity among women with PPH. Due to moderate quality evidence, this drug is recommended only in cases in which oxytocin and other uterotonics are not able to stop hemorrhaging.
Another product technology that was assessed in European countries was the transparent plastic collection bag. A multicenter RCT assessed its efficacy in preventing severe PPH, based on the measurement of blood lost after vaginal birth. The results reveal no significant differences when blood loss was measured using a collector bag or only visually verified. The authors note that more studies are needed to develop strategies able to decrease severe PPH by improving care management (53) .
In regard to process technologies, we initially verified that some authors conducted RCTs (54, 60) and an observational study (61) Decreased blood loss has a greater impact on the health of women in low-income countries (54, 60) ; however, if active management is the preferred option for AMTSL among low-risk women in high-level hospitals in developed countries, the only benefit will be to decrease drops in hemoglobin caused by childbirth (54) .
Another technology used to prevent PPH is the controlled cord traction (CCT) adopted in vaginal .
Still in regard to the prevention of PPH, the efficacy of skin-to-skin contact and breastfeeding after birth in decreasing PPH rates were also investigated. Risk for PPH decreased by almost four times among women practicing these. The highest effect in this study was among women at a lower risk of PPH. Both practices, when implemented immediately after birth, might be efficacious in decreasing PPH rates, regardless of the already existing risk factors for PPH (62) .
According to the authors, these practices promote the release of endogenous oxytocin, and they emphasize that pregnant women should be educated and supported in the implementation of these practices during the third and fourth stage of labor (62) . Note, however, these that the application of such practices should include a rigorous assessment of the clinical conditions of the women, because such a resource is not viable for those with at-risk pregnancies.
In regard to technology intended to prevent and control severe PPH and maternal morbidity and mortality, one paper addressed here focuses on sustained transabdominal uterine massage. The multicenter RCT (57) verified whether this technology can decrease blood loss receiving the massage and asked for it to be stopped (57) .
Routine uterine massage is not a technology indicated for the prevention of PPH after vaginal childbirth. It is a time-consuming and painful procedure and eliminating this practice from AMTSL benefits the obstetrical team because, in addition to saving effort, the time used in its application can be directed to other tasks (57) .
Another technology addressed is an educational intervention. Whether the implementation of a protocol of early PPH prevention decreased the incidence of severe PPH was assessed. The pregnant women involved were randomly assigned to the educational intervention (where sensitization meetings were held and the protocol was discussed) or only received the protocol without interventions. The results show that the mean rate of severe PPH did not differ in the units that received the educational intervention. Some elements of the PPH prevention protocol, however, were more frequently used in the units that received the intervention, such as asking for the help of specialized personnel and asking for specialized service within 15 minutes of PPH being diagnosed (58) . The authors emphasize that educational interventions are increasingly necessary to improve clinical practices in the face of new technologies and changes implemented in care components.
Some limitations were identified in this systematic
review. A total of 39 RCTs were found and, a priori, one assumes these present equivalent scientific rigor and evidence. After applying the GRADE system, however, a lack of methodological rigor was identified in 13 studies, which were classified as presenting low Cross-referencing with other descriptors should also be considered in future studies. 
Conclusion
